ILiAD Biotechnologies Receives NIH Grant to Develop Novel Tuberculosis Vaccine using proprietary…
ILiAD Biotechnologies announced that the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) has…